NCT01019473 Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea Status TERMINATED Phase PHASE2
NCT01018693 A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance Status COMPLETED Phase PHASE2
NCT01018225 Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness Status WITHDRAWN Phase PHASE4
NCT01012739 Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices Status COMPLETED Phase PHASE2
NCT01009346 RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN Status TERMINATED Phase PHASE1/PHASE2
NCT01009281 An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT01007968 Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function Status COMPLETED Phase PHASE1
NCT01007942 Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT01007149 Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT01005797 Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers Status COMPLETED Phase PHASE1
NCT01004510 Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01004224 A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT00999908 Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity Status COMPLETED Phase PHASE3
NCT00997477 Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics Status WITHDRAWN Phase PHASE4
NCT00997399 Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function Status COMPLETED Phase PHASE1